RheOx Device for Chronic Bronchitis
(Gala_EFS Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop all current medications, but if you are on anticoagulants (blood thinners), you must be able to stop them for at least seven days before the procedure. Also, you cannot participate if you are taking more than 10 mg of prednisolone or prednisone per day.
What data supports the effectiveness of the RheOx treatment for chronic bronchitis?
Research on similar treatments, like the Lung Flute and oscillating positive expiratory pressure (OPEP) devices, shows they can help clear mucus and improve symptoms in conditions like chronic bronchitis and COPD. These devices have been associated with fewer disease flare-ups and better quality of life, suggesting that RheOx might offer similar benefits.12345
How is the RheOx treatment for chronic bronchitis different from other treatments?
The RheOx treatment for chronic bronchitis is unique because it involves a device that regulates breathing by providing resistance to exhalation, which helps prevent over-breathing and improves symptoms without the need for drugs or hormones, unlike traditional treatments that often rely on medication.678910
What is the purpose of this trial?
This trial is testing a device called RheOx, which uses energy to treat the inner layers of the airways in patients with chronic bronchitis. The treatment involves two sessions, one for each lung, performed a few weeks apart. The goal is to see if this approach can safely help improve breathing in these patients.
Eligibility Criteria
This trial is for adults with chronic bronchitis for at least two years, an FEV1 between 30-80% of predicted, and a history of COPD exacerbations. They must have smoked the equivalent of ten pack-years and be able to undergo bronchoscopies. Exclusions include recent arrhythmias or lung cancer, severe other medical conditions, participation in another study within six weeks, inability to walk over 100 meters in six minutes, recent smoking or respiratory infections.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Two sessions of RheOx treatment delivered one month apart, targeting the right lung first and then the left lung
Follow-up
Participants are monitored for safety and effectiveness after treatment, including tests such as CT scans, respiratory function tests, and exercise testing
Treatment Details
Interventions
- RheOx
Find a Clinic Near You
Who Is Running the Clinical Trial?
Gala Therapeutics, Inc.
Lead Sponsor